A developer on MultiVersus has hinted that Scorpion from Mortal Kombat is set to hit the brawler.

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative ...

DALLAS, June 26, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe ...

/PRNewswire/ -- Blue Earth Therapeutics today announced radiation dosimetry results for its radiohybrid lutetium labelled, PSMA targeted, investigational ...

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives By Leap Therapeutics, Inc.

Once closed, Verve Therapeutics will be Lilly’s third targeted M&A deal this year. In January, it signed a $2.5 billion deal for Scorpion Therapeutics’ experimental oncology drug, STX-478, a ...

MILPITAS, Calif. , June 18, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced that Dr. Michael ...

Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced that Dr. Michael Alexander, a highly distinguished specialist in ...

Pierre Fabre Laboratories, the world's second-largest dermo-cosmetics company and one of Europe's leading pharmaceutical laboratories, announced the acquisition from Antares Therapeutics, Inc.

Most notably, it acquired Scorpion Therapeutics and its PI3Kα inhibitor program for $2.5 billion in January. The deal for Verve is expected to close in the third quarter.

BOSTON, June 18, 2025 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today ...